Efficacy of the Anti‐Candida rAls3p‐N or rAls1p‐N Vaccines against Disseminated and Mucosal Candidiasis

Cited by (180)

Items 101–180 of 180

1. Immunotherapy of Fungal Infections
   Kausik Datta, Mawieh A. Hamad · 2015 · Immunological Investigations
2. New antifungal strategies and drug development against WHO critical priority fungal pathogens
   Yanjian Li, Yang Liu, Yicong Jiang, Yuan Yang, Wanxing Ni, Wanli Zhang, Lingchen Tan · 2025 · Frontiers in Cellular and Infection Microbiology
3. Prospects for Development of a Vaccine to Prevent and Control Vaginal Candidiasis
   Paul L. Fidel, Jim E. Cutler · 2010 · Current Infectious Disease Reports
4. “Molding” immunity—modulation of mucosal and systemic immunity by the intestinal mycobiome in health and disease
   Mackenzie W. Gutierrez, Erik van Tilburg Bernardes, Diana Changirwa, Braedon McDonald, Marie‐Claire Arrieta · 2022 · Mucosal Immunology
5. Harnessing the Immune Response to Fungal Pathogens for Vaccine Development
   Amariliz Rivera, Jennifer K. Lodge, Chaoyang Xue · 2022 · Annual Review of Microbiology
6. Accessibility and contribution to glucan masking of natural and genetically tagged versions of yeast wall protein 1 of Candida albicans
   Bruce L. Granger · 2018 · PLoS ONE
7. Moonlighting proteins in medically relevant fungi
   Verania Arvizu-Rubio, Laura Cristina García-Carnero, Hector Manuel Mora-Montes · 2022 · PeerJ
8. Fungal Vaccine Development: State of the Art and Perspectives Using Immunoinformatics
   Moisés Morais Inácio, André Luís Elias Moreira, Vanessa Rafaela Milhomem Cruz-Leite, Karine Mattos, Lana O’Hara Souza Silva, James Venturini, Orville Hernandez Ruiz, Fátima Ribeiro‐Dias, Simone Schneider Weber, Célia Maria de Almeida Soares et al. · 2023 · Journal of Fungi
9. Immunological surrogate marker of rAls3p-N vaccine-induced protection againstStaphylococcus aureus: Table 1
   Lin Lin, Ashraf S. Ibrahim, Beverlie Baquir, Valentina Avanesian, Yue Fu, Brad J. Spellberg · 2009 · FEMS Immunology & Medical Microbiology
10. Promising immunotherapeutic targets for treating candidiasis
    Zhe Chuan Feng, Hui Lu, Yuanying Jiang · 2024 · Frontiers in Cellular and Infection Microbiology
11. Toll-like receptor 4 (TLR4) is the major pattern recognition receptor triggering the protective effect of a Candida albicans extracellular vesicle-based vaccine prototype in murine systemic candidiasis
    Leandro Honorato, Jhon Jhamilton Artunduaga Bonilla, Alessandro Fernandes Valdez, Susana Frasés, Glauber Ribeiro de Sousa Araújo, Albaniza Liuane Ribeiro do Nascimento Sabino, Natalia Martins da Silva, Larissa Ribeiro, Marina da Silva Ferreira, Julio Kornetz et al. · 2024 · mSphere
12. Application of anti-fungal vaccines as a tool against emerging anti-fungal resistance
    Ravinder Kumar, Vartika Srivastava · 2023 · Frontiers in Fungal Biology
13. Candidaantigens and immune responses: implications for a vaccine
    Maria Dolores Moragues, Aitor Rementerı́a, María Jesús Sevilla, Elena Eraso, Guillermo Quindós · 2014 · Expert Review of Vaccines
14. Synthesis and immunological studies of β-1,2-mannan-peptide conjugates as antifungal vaccines
    Jun Liao, Bo Pan, Guochao Liao, Qingjie Zhao, Yun Liang Gao, Xiaoyun Chai, Xiaobin Zhuo, Qiuye Wu, Binghua Jiao, Weihua Pan et al. · 2019 · European Journal of Medicinal Chemistry
15. Advancing Vaccine Strategies against Candida Infections: Exploring New Frontiers
    Gurpreet Kaur, Sonam Chawla, Piyush Kumar, Ritu Singh · 2023 · Vaccines
16. Adhesins in Opportunistic Fungal Pathogens
    R. Zordan, B. Cormack · 2012 · ASM Press eBooks
17. A Mass Spectrometric View of the Fungal Wall Proteome
    Frans M. Klis, Chris G. de Koster, Stanley Brul · 2011 · Future Microbiology
18. Immune Modulators as Adjuncts for the Prevention and Treatment of Invasive Fungal Infections
    Regina Pikman, Ronen Ben‐Ami · 2012 · Immunotherapy
19. Considerable Differences in Vaccine Immunogenicities and Efficacies Related to the Diluent Used for Aluminum Hydroxide Adjuvant
    Lin Lin, Ashraf S. Ibrahim, Valentina Avanesian, John Ernest Edwards, Yue Fu, Beverlie Baquir, Rebecca Taub, Brad J. Spellberg · 2008 · Clinical and Vaccine Immunology
20. Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus
    Michael R. Yeaman, Scott G. Filler, Clint S. Schmidt, Ashraf S. Ibrahim, John Ernest Edwards, John P. Hennessey · 2014 · Frontiers in Immunology
21. Safety, Immunogenicity, and Efficacy of NDV-3A against Staphylococcus aureus Colonization: A Phase 2 Vaccine Trial among US Army Infantry Trainees
    Eugene V. Millar, J. Bennett, B. Barin, Patrick M. Carey, Natasha N. Law, C. English, Michael M Schwartz, Terrence Cochrane, Michael W. Ellis, D. Tribble et al. · 2021 · Vaccine
22. Candida spp. and phagocytosis: multiple evasion mechanisms
    Josidel Conceição Oliver, Carla Benedini Ribeiro Jorge Ferreira, Naiara Chaves Silva, Amanda Latércia Tranches Dias · 2019 · Antonie van Leeuwenhoek
23. Immunization with Pneumocystis Cross-Reactive Antigen 1 (Pca1) Protects Mice against Pneumocystis Pneumonia and Generates Antibody to Pneumocystis jirovecii
    Brenda L. Tesini, Terry W. Wright, Jane E. Malone, Constantine G. Haidaris, Martha Harber, Andrea J. Sant, Jennifer Lynn Nayak, Francis Gigliotti · 2016 · Infection and Immunity
24. T cell Immunity and Vaccines Against Invasive Fungal Diseases
    James I. Ito · 2011 · Immunological Investigations
25. Opportunities and Obstacles in the Prevention of Skin and Soft-Tissue Infections Among Military Personnel
    Eugene V. Millar, Carey D. Schlett, Natasha N. Law, T. Whitman, Michael W. Ellis, D. Tribble, LeRoy Bennett · 2019 · Military Medicine
26. Applying the Host-Microbe Damage Response Framework to Candida Pathogenesis: Current and Prospective Strategies to Reduce Damage
    Paul L. Fidel, Junko Yano, Shannon K. Esher, Mairi C. Noverr · 2020 · Journal of Fungi
27. Our pursuit for effective antifungal agents targeting fungal cell wall components: where are we?
    Chibuike Ibe, Rita Okeoghene Oladele, Omran Alamir · 2021 · International Journal of Antimicrobial Agents
28. Exploiting new knowledge of Candidal infection for future antifungal combat
    Camilla Kragelund · 2016 · Oral Diseases
29. Structural basis of Blastomyces Endoglucanase-2 adjuvancy in anti-fungal and -viral immunity
    Lucas dos Santos Dias, Hannah E. Dobson, Brock A. Kingstad-Bakke, Gregory C. Kujoth, Junfeng Huang, Elaine M. Kohn, Cleison Ledesma Taira, Huafeng Wang, Nitin T. Supekar, Jeffrey Scott Fites et al. · 2021 · PLoS Pathogens
30. Antibodies to Combat Fungal Infections: Development Strategies and Progress
    Ali Ahmed Rabaan, Amal H. Alfaraj, Amer Alshengeti, Abdulsalam Alawfi, Sara M. Alwarthan, Mashael M. Alhajri, Amal Hassan Al-Najjar, Mona A. Al Fares, Mustafa A. Najim, Souad A. Almuthree et al. · 2023 · Microorganisms
31. Staphylococcus aureus
    Isaac P. Thomsen, Clarence Buddy Creech · 2022 · Elsevier eBooks
32. The Cell Wall: Glycoproteins, Remodeling, and Regulation
    Carol A. Munro, Mathias L. Richard · 2014 · ASM Press eBooks
33. The prevalence and risk factors of vaginal Candida species and group B Streptococcus colonization in pregnant women attending antenatal care at Hawassa university comprehensive specialized hospital in Hawassa City, Southern Ethiopia
    Atenaf Eskezia, Abraham Mikru, Tsegaye Alemayehu · 2025 · BMC Pregnancy and Childbirth
34. Innovative Approaches to Improve Anti-Infective Vaccine Efficacy.
    M. Yeaman, J. Hennessey · 2017 · Annual Review of Pharmacology and Toxicology
35. Current Trends in Candidiasis
    Priya Uppuluri, Afshin Alaf Khan, John Ernest Edwards · 2017 · Springer eBooks
36. Unlocking the Therapeutic Potential of the Fungal Cell Wall: Clinical Implications and Drug Resistance
    Chibuike Ibe, Louise A. Walker, Neil A. R. Gow, Carol A. Munro · 2017 · Springer eBooks
37. Consensus Report on Diagnosis, Treatment and Prevention of Infective Endocarditis by Turkish Society of Cardiovascular Surgery (TSCVS), Turkish Society of Clinical Microbiology and Infectious Diseases (KLIMIK), Turkish Society of Cardiology (TSC), Turkish Society of Nuclear Medicine (TSNM), Turkish Society of Radiology (TSR), Turkish Dental Association (TDA) and Federation of Turkish Pathology Societies (TURKPATH) Cardiovascular System Study Group
    Serap Şimşek Yavuz · 2020 · Turkish Journal of Thoracic and Cardiovascular Surgery
38. Fungal Biofilms: Inside Out
    Katherine Lagree, Aaron P. Mitchell · 2017 · ASM Press eBooks
39. Animal Models In Mycology: What Have We Learned Over The Past 30 Years
    William R. Kirkpatrick, Nathan P. Wiederhold, Laura K. Najvar, Thomas F. Patterson · 2012 · Current Fungal Infection Reports
40. Genome-wide scan for potential CD4+ T-cell vaccine candidates in Candida auris by exploiting reverse vaccinology and evolutionary information
    Shishir Kumar Gupta, Özge Osmanoğlu, Rashmi Minocha, Sourish Reddy Bandi, Elena Bencúrová, Mugdha Srivastava, Thomas Dandekar · 2022 · Frontiers in Medicine
41. Fungal vaccines and adjuvants: a tool to reveal the interaction between host and fungi
    Zixu Wang, Jing Shao · 2024 · Archives of Microbiology
42. Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections
    Shakti Singh, Eman G. Youssef, Ashley M Barbarino, Haley Hautau, Sunna Nabeela, Teclegiorgis Gebremariam, Sondus Alkhazraji, Gary R. Ostroff, Dennis Christensen, Terrence Cochrane et al. · 2025 · Scientific Reports
43. The Road Ahead: Advancing Antifungal Vaccines and Addressing Fungal Infections in the Post-COVID World
    Xiaolong Gong, Mohmmad Younus Wani, Abdullah S. Al‐Bogami, Aijaz Ahmad, Keven Mara Robinson, Amber Khan · 2024 · ACS Infectious Diseases
44. Interactions of Extracellular Vesicles from Pathogenic Fungi with Innate Leukocytes
    Mateus Silveira Freitas, André Moreira Pessoni, Carolina Coelho, Vânia Luiza Deperon Bonato, Márcio Lourenço Rodrigues, Arturo Casadevall, Fausto Bruno dos Reis Almeida · 2021 · Current topics in microbiology and immunology
45. Whole recombinant yeast-based vaccines: concept, importance, issues, and future scope
    Ravinder Kumar, Vartika Srivastava, Aijaz Ahmad, Santi M. Mandal, Piyush Baindara · 2025 · Critical Reviews in Biotechnology
46. Candidozyma auris Alert in South America: An Epidemiological and Therapeutic Update
    Gabriel Davi Marena, Joshua Daniel Nosanchuk, Carlos P. Taborda · 2025 · Current Tropical Medicine Reports
47. Communication between immune system and mycobiota impacts health and disease
    Gunjan Sachdeva, Asmita Das · 2022 · Proceedings of the Indian National Science Academy
48. Vaccination with Recombinant Non-transmembrane Domain of Protein Mannosyltransferase 4 Improves Survival during Murine Disseminated Candidiasis
    Li Wang, Lan Yan, Xing Xing Li, Guo Tong Xu, Mao‐Mao An, Yuan Ying Jiang · 2015 · Biological and Pharmaceutical Bulletin
49. Prospects for and barriers to a fungal vaccine
    Brad J. Spellberg · 2007 · Expert Opinion on Biological Therapy
50. From High Protection to Lethal Effect: Diverse Outcomes of Immunization Against Invasive Candidiasis with Different Candida albicans Extracellular Vesicles
    Raquel Martínez‐López, Gloria Molero, Claudia Marcela Parra‐Giraldo, Matías Sebastián Cabeza, Guillermo Castejón, Carmen García-Durán, Luis Felipe Clemente, María Luisa Hernáez, Concha Gil, Lucía Monteoliva · 2024 · International Journal of Molecular Sciences
51. Immunomodulatory Agents as Adjunctive Therapy for the Treatment of Resistant Candida Species
    Nicholas D. Beyda, Sloan Regen, Russell Edward Lewis, Kevin W. Garey · 2013 · Current Fungal Infection Reports
52. Perspective on receptor-associated immune response to Candida albicans single and mixed infections: Implications for therapeutics in oropharyngeal candidiasis
    Liu Yang, Ting Cheng, Jing Shao · 2023 · Medical Mycology
53. Immunotherapy of Fungal Infections
    Kausik Datta, Liise‐anne Pirofski · 2017 · Elsevier eBooks
54. Candida albicans, Cryptococcus neoformans or Aspergillus fumigatus Induces an Antifungal Activity in Mouse Serum, which is Different from Transferrin
    Ken-ichi OKAZAKI, Masahiro Asakura, Norihiko Sugimoto, Atsushi Hinenoya, Shinji Yamasaki · 2009 · Journal of Veterinary Medical Science
55. Candida Infections: An Update on Host Immune Defenses and Anti-Fungal Drugs
    Ning Gao, Changbin Chen · 2016
56. Insights in Antifungal Drug Discovery
    Françoise Gay‐Andrieu, Jared P. May, Dongmei Li, Nuo Sun, Hui Chen, Richard Calderone, Deepu Alex · 2014 · ASM Press eBooks
57. Comprehensive review of fungal pathogenesis and antifungal therapeutics
    Borsa Rani Neog, Jyotirmoy Das, Biplab Das, Kalyani Pathak, Manisha Sahariah, Riya Saikia, Jon Jyoti Sahariah · 2025 · Discover Medicine
58. The MAP Kinase Network As the Nervous System of Fungi
    Inês Correia, Daniel Prieto, Rebeca Alonso‐Monge, Jesús Plá, Elvira Román · 2016 · Elsevier eBooks
59. Infection-Associated Gene Expression—The Pathogen Perspective
    Saranna Fanning, Aaron P. Mitchell · 2017 · Springer eBooks
60. Oral candidose – diagnostik, forebyggelseog behandlingsstrategi
    Camilla Kragelund, Mette Rose Jørgensen · 2017 · Aktuel nordisk odontologi
61. Vaccines for fungal infections.
    Urvashi Tiwari, Shukla Das, Mukta Tandon, V. G. Ramachandran, Rumpa Saha · 2015 · PubMed
62. Faculty Opinions recommendation of The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection.
    Sarah L. Gaffen, Rami Bechara · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
63. Animal Models of Mucosal Candida Infections
    Flavia De Bernardis, Silvia Arancia, Silvia Sandini · 2010 · Methods in microbiology
64. The role of adjuvant agents in treating fungal diseases
    Shellee A. Grim, Nina M. Clark · 2009 · Current Fungal Infection Reports
65. CANDIDA YEASTS AND CARCINOGENIC ACETALDEHYDE IN UPPER DIGESTIVE TRACT CARCINOGENESIS
    Mikko T. Nieminen · 2014 · Työväentutkimus Vuosikirja
66. Spécificité antigénique de l'Als3p de Candida albicans et implication de cette protéine dans l'interaction avec les constituants de l'hôte
    École Doctorale · 2007
67. Immunization Protocols for Use in Animal Models of Candidiasis
    Esther Segal, Hana Sandovsky‐Losica · 2009 · Methods in molecular biology
68. Vaccination Against Fungal Diseases: Lessons from Candida albicans
    Paula Sampaio, Célia Pais · 2017 · Springer eBooks
69. Vaccines and Passive Immunity against Candidiasis
    B. Spellberg, Yue Fu, A. Ibrahim · 2012 · ASM Press eBooks
70. The MAP Kinase Network As the Nervous System of Fungi
    Inês Correia, Daniel Prieto, Rebeca Alonso‐Monge, Jesús Plá, Elvira Román · 2017 · Elsevier eBooks
71. Immunotherapy of Fungal Infections
    Kausik Datta, Liise‐anne Pirofski · 2017 · Elsevier eBooks
72. Peer Review #3 of "Moonlighting proteins in medically relevant fungi (v0.1)"
    2022 · PeerJ
73. Peer Review #1 of "Moonlighting proteins in medically relevant fungi (v0.1)"
    2022 · PeerJ
74. Peer Review #2 of "Moonlighting proteins in medically relevant fungi (v0.1)"
    2022 · PeerJ
75. Recent trends and progress in antifungal translational research
    Awanish Kumar, Anubhuti Jha · 2023 · Elsevier eBooks
76. Fungal Vaccines: Recent Trends
    Mohammad Shahid, Abida Malik, Noor Jahan, Hamdan Ibrahim AL-Mohammed, Ali Ibrahim Al‐Sultan, Elsayed Aboulmagd · 2010 · Springer eBooks
77. INTERLEUKIN-17-MEDIATED ADAPTIVE IMMUNITY TO CANDIDA ALBICANS IN OROPHARYNGEAL CANDIDIASIS
    Nydiaris Hernández‐Santos · 2012 · D-Scholarship@Pitt (University of Pittsburgh)
78. Antifungal drug resistance: Current mechanisms and future directions
    Mengjun Tang, Liangsheng Fan, Liang Shen, Hui Xing · 2026 · Elsevier eBooks
79. Rôle des polysaccharides fongiques et du microbiote intestinal dans la clairance digestive de Candida glabrata
    Rogatien Charlet · 2022
80. Solving the Staphylococcus aureus puzzle: lessons to guide future MRSA vaccine development
    Eleanor Mills, Mark P. Del Borgo, Meredith A O’Keeffe · 2026 · Clinical Microbiology Reviews